Company AIT Therapeutics Inc Other OTC
Equities
US50027L1070
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 30 | Truist Lowers Price Target on Beyond Air to $8 From $10, Keeps Buy Rating | MT |
Feb. 12 | Beyond Air, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Steven Lisi
CEO | Chief Executive Officer | 53 | 17-01-12 |
Douglas Larson
DFI | Director of Finance/CFO | 53 | 21-08-31 |
Amir Avniel
PSD | President | 50 | 17-01-12 |
Andrew Colin
CTO | Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Chief Tech/Sci/R&D Officer | - | - | |
Jeff Myers
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-26 |
Michael Gaul
COO | Chief Operating Officer | 70 | 20-04-30 |
Edward Barger
IRC | Investor Relations Contact | - | 22-09-30 |
Kori-Ann Taylor
SAM | Sales & Marketing | - | 21-05-19 |
Peter Senior
PRN | Corporate Officer/Principal | - | 21-05-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Bentsur
BRD | Director/Board Member | 58 | 15-07-31 |
William Forbes
BRD | Director/Board Member | 62 | 18-08-12 |
Erick Lucera
BRD | Director/Board Member | 57 | 17-08-09 |
Steven Lisi
CEO | Chief Executive Officer | 53 | 17-01-12 |
Amir Avniel
PSD | President | 50 | 17-01-12 |
Robert Carey
BRD | Director/Board Member | 65 | 19-02-12 |
Yoori Lee
BRD | Director/Board Member | 51 | 18-01-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 45,898,321 | 37,646,892 ( 82.02 %) | 0 | 82.02 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-4.17% | 184B | |
-0.78% | 108B | |
-3.21% | 67.82B | |
+4.39% | 51.05B | |
+8.76% | 44.67B | |
+3.40% | 41.78B | |
+3.24% | 26.78B | |
+4.27% | 26.59B | |
+15.23% | 25.86B |
- Stock Market
- Equities
- XAIR Stock
- Stock
- Company AIT Therapeutics Inc